Antitrust agencies could be sympathetic toward the deal, given Steward’s financial distress and important hospital portfolio. But sympathy won’t shield the deal from scrutiny, an expert told Healthcare Dive.
Antitrust agencies could be sympathetic toward the deal, given Steward’s financial distress and important hospital portfolio. But sympathy won’t shield the deal from scrutiny, an expert told Healthcare Dive.